Tax Deregulation of NF-κB2 p100 Processing Involves Both β-TrCP-dependent and -independent Mechanisms*

Processing of the nf-κb2 gene product p100 to generate p52 is a tightly regulated event, consistent with the fact that the processing product, p52, is hardly detected in most cell types, including T cells, although the precursor p100 is expressed abundantly in these cells. However, in T cells transformed by the human T-cell leukemia virus type I (HTLV-I), p100 processing is very active, resulting in high level expression of p52. Because overproduction of p52 is associated with lymphoid hyperplasia and transformation, deregulation of p100 processing may be part of the oncogenic mechanism of HTLV-I. We demonstrated previously that HTLV-I Tax oncoprotein is a potent inducer of p100 processing through specific targeting of IKKα via IKKγ to p100 to trigger p100 phosphorylation and ubiquitination. In this study, we further show that Tax-mediated recruitment of IKKα to p100 requires serines 866 and 870 of p100, shown to be essential for inducible processing of p100. Upon interaction with p100, activated IKKα phosphorylates both N- and C-terminal serines of p100 (serines 99, 108, 115, 123 and 872), serving as a critical step in Tax-induced p100 processing. Using a genetic approach, we find that β-transducin repeat-containing protein, a component of the SCF ubiquitin ligase complex, previously shown to be required for physiological p100 processing mediated by nuclear factor-κB-inducing kinase, is only partially involved in Tax-induced processing of p100. These results indicate that both β-transducin repeat-containing protein-dependent and -independent mechanisms contribute to Tax-deregulated p100 processing, further suggesting the involvement of different mechanisms in cellular and viral pathways of p100 processing.

[1]  G. Xiao,et al.  Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.

[2]  G. Xiao,et al.  Deregulation of NF-κB and its upstream kinases in cancer , 2003, Cancer and Metastasis Reviews.

[3]  Shao-Cong Sun,et al.  Regulation of NF-κB2/p100 processing by its nuclear shuttling , 2003, Oncogene.

[4]  B. Huhse,et al.  CD40 regulates the processing of NF‐κB2 p100 to p52 , 2002 .

[5]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[6]  D. Seshasayee,et al.  BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. , 2002, Immunity.

[7]  Hong-shan Wang,et al.  BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells , 2002, Nature Immunology.

[8]  A. Fong,et al.  Genetic Evidence for the Essential Role of β-Transducin Repeat-containing Protein in the Inducible Processing of NF-κB2/p100* , 2002, The Journal of Biological Chemistry.

[9]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[10]  G. Bren,et al.  RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100* , 2002, The Journal of Biological Chemistry.

[11]  E. Harhaj,et al.  Retroviral oncoprotein Tax induces processing of NF‐κB2/p100 in T cells: evidence for the involvement of IKKα , 2001 .

[12]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[13]  J. Tschopp,et al.  BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF , 2001, Science.

[14]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[15]  E. Harhaj,et al.  Domain-specific Interaction with the IκB Kinase (IKK) Regulatory Subunit IKKγ Is an Essential Step in Tax-mediated Activation of IKK* , 2000, The Journal of Biological Chemistry.

[16]  G. Xiao,et al.  Activation of IKKα and IKKβ through their fusion with HTLV-I Tax protein , 2000, Oncogene.

[17]  G. Xiao,et al.  Negative Regulation of the Nuclear Factor κB-inducing Kinase by a cis-Acting Domain* , 2000, The Journal of Biological Chemistry.

[18]  W. Funkhouser,et al.  Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 , 2000, Oncogene.

[19]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[20]  E. Harhaj,et al.  IKKγ Serves as a Docking Subunit of the IκB Kinase (IKK) and Mediates Interaction of IKK with the Human T-cell Leukemia Virus Tax Protein* , 1999, The Journal of Biological Chemistry.

[21]  K. Jeang,et al.  Role of Adapter Function in Oncoprotein-mediated Activation of NF-κB , 1999, The Journal of Biological Chemistry.

[22]  D. Ballard,et al.  IKKγ Mediates the Interaction of Cellular IκB Kinases with the Tax Transforming Protein of Human T Cell Leukemia Virus Type 1* , 1999, The Journal of Biological Chemistry.

[23]  W. Greene,et al.  Human T-Cell Leukemia Virus Type 1 Tax Induction of NF-κB Involves Activation of the IκB Kinase α (IKKα) and IKKβ Cellular Kinases , 1998, Molecular and Cellular Biology.

[24]  E. Zandi,et al.  NF-κB-inducing Kinase and IκB Kinase Participate in Human T-cell Leukemia Virus I Tax-mediated NF-κB Activation* , 1998, The Journal of Biological Chemistry.

[25]  K. Pfeffer,et al.  The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. , 1998, Immunity.

[26]  A. Leonardi,et al.  Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture , 1998, The Journal of experimental medicine.

[27]  C. Snapper,et al.  Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.

[28]  Gregory L. Verdine,et al.  Structure of the human NF‐κB p52 homodimer‐DNA complex at 2.1 Å resolution , 1997 .

[29]  D. Carrasco,et al.  Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2 , 1997, The Journal of experimental medicine.

[30]  A. Neri,et al.  Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts , 1997, Oncogene.

[31]  G. Nabel,et al.  Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences , 1996, Molecular and cellular biology.

[32]  S. Yamaoka,et al.  Constitutive activation of NF‐kappa B is essential for transformation of rat fibroblasts by the human T‐cell leukemia virus type I Tax protein. , 1996, The EMBO journal.

[33]  G. Perini,et al.  Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax , 1995, Nature.

[34]  A. Schepartz,et al.  Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax , 1995, Nature.

[35]  David Baltimore,et al.  Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.

[36]  C. Gélinas,et al.  Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. , 1994, Oncogene.

[37]  L. Lombardi,et al.  Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. , 1994, Oncogene.

[38]  Scott F. Smith,et al.  Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. , 1994, Science.

[39]  J. Hiscott,et al.  Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway. , 1994, Oncogene.

[40]  W. Greene,et al.  Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency , 1994, Molecular and cellular biology.

[41]  S. Ikehara,et al.  A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice , 1994, European journal of immunology.

[42]  M. Green,et al.  HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. , 1993, Science.

[43]  L. Cro,et al.  Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. , 1993, Oncogene.

[44]  M. Karin,et al.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. , 1993, Genes & development.

[45]  A. Israël,et al.  The precursor of NF-κB p50 has IκB-like functions , 1992, Cell.

[46]  L. Zhao,et al.  Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Maniatis,et al.  Generation of p50 subunit of NF-kB by processing of p105 through an ATP-dependent pathway , 1991, Nature.

[48]  W. Greene,et al.  Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. , 1991, The Journal of clinical investigation.

[49]  W. Greene,et al.  Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. , 1990, Genes & development.

[50]  T. Maniatis,et al.  NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .

[51]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[52]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[53]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.